Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.

Irace C, Cutruzzolà A, Nuzzi A, Assaloni R, Brunato B, Pitocco D, Tartaglione L, Di Molfetta S, Cignarelli A, Laviola L, Citro G, Lovati E, Gnasso A, Tweden KS, Kaufman FR.

Diabetes Obes Metab. 2020 Feb 9. doi: 10.1111/dom.13993. [Epub ahead of print]

PMID:
32037699
2.

Pasta Consumption and Connected Dietary Habits: Associations with Glucose Control, Adiposity Measures, and Cardiovascular Risk Factors in People with Type 2 Diabetes-TOSCA.IT Study.

Vitale M, Masulli M, Rivellese AA, Bonora E, Babini AC, Sartore G, Corsi L, Buzzetti R, Citro G, Baldassarre MPA, Bossi AC, Giordano C, Auciello S, Dall'Aglio E, Iannarelli R, Tonutti L, Sacco M, Di Cianni G, Clemente G, Gregori G, Grioni S, Krogh V, Riccardi G, Vaccaro O.

Nutrients. 2019 Dec 30;12(1). pii: E101. doi: 10.3390/nu12010101.

3.

RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer.

Carafa V, Nebbioso A, Cuomo F, Rotili D, Cobellis G, Bontempo P, Baldi A, Spugnini EP, Citro G, Chambery A, Russo R, Ruvo M, Ciana P, Maravigna L, Shaik J, Radaelli E, De Antonellis P, Tarantino D, Pirolli A, Ragno R, Zollo M, Stunnenberg HG, Mai A, Altucci L.

Clin Cancer Res. 2018 Jun 15;24(12):2886-2900. doi: 10.1158/1078-0432.CCR-17-3081. Epub 2018 Mar 13.

4.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, Rivellese AA, Squatrito S, Giorda CB, Sesti G, Mocarelli P, Lucisano G, Sacco M, Signorini S, Cappellini F, Perriello G, Babini AC, Lapolla A, Gregori G, Giordano C, Corsi L, Buzzetti R, Clemente G, Di Cianni G, Iannarelli R, Cordera R, La Macchia O, Zamboni C, Scaranna C, Boemi M, Iovine C, Lauro D, Leotta S, Dall'Aglio E, Cannarsa E, Tonutti L, Pugliese G, Bossi AC, Anichini R, Dotta F, Di Benedetto A, Citro G, Antenucci D, Ricci L, Giorgino F, Santini C, Gnasso A, De Cosmo S, Zavaroni D, Vedovato M, Consoli A, Calabrese M, di Bartolo P, Fornengo P, Riccardi G; Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group; Italian Diabetes Society.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917544
5.

Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.

Loche S, Salerno M, Garofalo P, Cardinale GM, Licenziati MR, Citro G, Caruso Nicoletti M, Cappa M, Longobardi S, Maghnie M, Perrone R.

J Endocrinol Invest. 2016 Dec;39(12):1419-1424. Epub 2016 Jul 12.

6.

Hypoparathyroidism after total thyroidectomy: prospective evaluation and relation with early hypocalcemia.

D'Alessandro N, Tramutola G, Fasano GM, Gilio F, Iside G, Izzo ML, Loffredo A, Pici M, Pinto M, Tramontano S, Citro G.

Ann Ital Chir. 2016;87:214-9.

PMID:
27346692
7.

Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes - The TOSCA.IT study.

Vitale M, Masulli M, Cocozza S, Anichini R, Babini AC, Boemi M, Bonora E, Buzzetti R, Carpinteri R, Caselli C, Ceccarelli E, Cignarelli M, Citro G, Clemente G, Consoli A, Corsi L, De Gregorio A, Di Bartolo P, Di Cianni G, Fontana L, Garofolo M, Giorda CB, Giordano C, Grioni S, Iovine C, Longhitano S, Mancastroppa G, Mazzucchelli C, Montani V, Mori M, Perriello G, Rinaldi ME, Ruffo MC, Salvi L, Sartore G, Scaranna C, Tonutti L, Zamboni C, Zogheri A, Krogh V, Cappellini F, Signorini S, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Nutr Metab Cardiovasc Dis. 2016 Oct;26(10):879-85. doi: 10.1016/j.numecd.2016.04.006. Epub 2016 Apr 16.

PMID:
27212622
8.

Increasing bioavailability of (R)-alpha-lipoic acid to boost antioxidant activity in the treatment of neuropathic pain.

Maglione E, Marrese C, Migliaro E, Marcuccio F, Panico C, Salvati C, Citro G, Quercio M, Roncagliolo F, Torello C, Brufani M.

Acta Biomed. 2015 Dec 14;86(3):226-33.

PMID:
26694149
9.

Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes-The TOSCA.IT Study.

Vitale M, Masulli M, Rivellese AA, Babini AC, Boemi M, Bonora E, Buzzetti R, Ciano O, Cignarelli M, Cigolini M, Clemente G, Citro G, Corsi L, Dall'Aglio E, Del Prato S, Di Cianni G, Dolci MA, Giordano C, Iannarelli R, Iovine C, Lapolla A, Lauro D, Leotta S, Mazzucchelli C, Montani V, Perriello G, Romano G, Romeo F, Santarelli L, di Cola RS, Squatrito S, Tonutti L, Trevisan R, Turco AA, Zamboni C, Riccardi G, Vaccaro O.

Eur J Nutr. 2016 Jun;55(4):1645-51. doi: 10.1007/s00394-015-0983-1. Epub 2015 Aug 25.

PMID:
26303195
10.

Surgical approach to TIR3 cytology class A prospective evaluation.

D'Alessandro N, Fasano GM, Gilio F, Iside G, Izzo ML, Loffredo A, Pinto M, Tramontano S, Tramutola G, Citro G.

Ann Ital Chir. 2014 Nov-Dec;85(6):537-43.

PMID:
25712947
11.

Timing of antioxidant supplementation is critical in improving anorexia in an experimental model of cancer.

Molfino A, De Luca S, Muscaritoli M, Citro G, Fazi L, Mari A, Ramaccini C, Rossi Fanelli F, Laviano A.

Int J Food Sci Nutr. 2013 Aug;64(5):570-4. doi: 10.3109/09637486.2012.759189. Epub 2013 Jan 9.

PMID:
23301688
12.

Preclinical models in electrochemotherapy: the role of veterinary patients.

Spugnini EP, Fanciulli M, Citro G, Baldi A.

Future Oncol. 2012 Jul;8(7):829-37. doi: 10.2217/fon.12.64. Review.

PMID:
22830403
13.

Endocrinology and art. The hermaphrodite figure in the National Archeological Museum of Melfi.

Lo Pomo F, Citro G, Zampino A.

J Endocrinol Invest. 2012 Apr;35(4):450. No abstract available.

PMID:
22652828
14.

Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.

Blandino G, Valerio M, Cioce M, Mori F, Casadei L, Pulito C, Sacconi A, Biagioni F, Cortese G, Galanti S, Manetti C, Citro G, Muti P, Strano S.

Nat Commun. 2012 May 29;3:865. doi: 10.1038/ncomms1859.

15.

SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation.

Falvo E, Strigari L, Citro G, Giordano C, Boboc G, Fabretti F, Bruzzaniti V, Bellesi L, Muti P, Blandino G, Pinnarò P.

J Exp Clin Cancer Res. 2012 Jan 24;31:7. doi: 10.1186/1756-9966-31-7.

16.

Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo).

Meschini S, Condello M, Lista P, Vincenzi B, Baldi A, Citro G, Arancia G, Spugnini EP.

Eur J Cancer. 2012 Sep;48(14):2236-43. doi: 10.1016/j.ejca.2011.11.031. Epub 2012 Jan 11.

PMID:
22240284
17.

Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.

Spugnini EP, Baldi A, Buglioni S, Carocci F, de Bazzichini GM, Betti G, Pantaleo I, Menicagli F, Citro G, Fais S.

J Transl Med. 2011 Dec 28;9:221. doi: 10.1186/1479-5876-9-221.

18.

Endocrine disruptors in utero cause ovarian damages linked to endometriosis.

Signorile PG, Spugnini EP, Citro G, Viceconte R, Vincenzi B, Baldi F, Baldi A.

Front Biosci (Elite Ed). 2012 Jan 1;4:1724-30.

PMID:
22201988
19.

Carnitine administration reduces cytokine levels, improves food intake, and ameliorates body composition in tumor-bearing rats.

Laviano A, Molfino A, Seelaender M, Frascaria T, Bertini G, Ramaccini C, Bollea MR, Citro G, Rossi Fanelli F.

Cancer Invest. 2011 Dec;29(10):696-700. doi: 10.3109/07357907.2011.626476.

PMID:
22085273
20.

Differential accumulation of BPA in some tissues of offspring of Balb-C mice exposed to different BPA doses.

Mita L, Baldi A, Diano N, Viggiano E, Portaccio M, Nicolucci C, Grumiro L, Menale C, Mita DG, Spugnini EP, Viceconte R, Citro G, Pierantoni R, Sica V, Marino M, Signorile PG, Bianco M.

Environ Toxicol Pharmacol. 2012 Jan;33(1):9-15. doi: 10.1016/j.etap.2011.09.008. Epub 2011 Oct 2.

PMID:
22047638
21.

SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.

Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, Borsellino G, Galati R, Battistini L, Blandino R, Facciolo F, Citro G, Strano S, Muti P, Blandino G, Cioce M.

Oncogene. 2012 Jun 28;31(26):3148-63. doi: 10.1038/onc.2011.485. Epub 2011 Oct 24.

22.

Tumor suppressors and cell-cycle proteins in lung cancer.

Baldi A, De Luca A, Esposito V, Campioni M, Spugnini EP, Citro G.

Patholog Res Int. 2011;2011:605042. doi: 10.4061/2011/605042. Epub 2011 Oct 5.

23.

Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs.

Spugnini EP, Renaud SM, Buglioni S, Carocci F, Dragonetti E, Murace R, Cardelli P, Vincenzi B, Baldi A, Citro G.

J Transl Med. 2011 Sep 14;9:152. doi: 10.1186/1479-5876-9-152.

24.

Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.

Baldi A, Piccolo MT, Boccellino MR, Donizetti A, Cardillo I, La Porta R, Quagliuolo L, Spugnini EP, Cordero F, Citro G, Menegozzo M, Calogero RA, Crispi S.

PLoS One. 2011;6(8):e23569. doi: 10.1371/journal.pone.0023569. Epub 2011 Aug 17.

25.

Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery.

Falvo E, Strigari L, Citro G, Giordano C, Arcangeli S, Soriani A, D'Alessio D, Muti P, Blandino G, Sperduti I, Pinnarò P.

BMC Cancer. 2011 Jul 12;11:291. doi: 10.1186/1471-2407-11-291.

26.

Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease.

D'Arcangelo G, Grossi D, De Chiara G, de Stefano MC, Cortese G, Citro G, Rufini S, Tancredi V, Merlo D, Frank C.

Brain Res. 2011 Jun 17;1396:11-9. doi: 10.1016/j.brainres.2011.04.020. Epub 2011 Apr 19.

PMID:
21575932
27.

Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs.

Spugnini EP, Vincenzi B, Citro G, Dotsinsky I, Mudrov T, Baldi A.

J Vet Intern Med. 2011 Mar-Apr;25(2):407-11. doi: 10.1111/j.1939-1676.2011.0678.x. Epub 2011 Feb 11.

28.

Omics underpins novel clues on VDR chemoprevention target in breast cancer.

Muti P, Benassi B, Falvo E, Santoro R, Galanti S, Citro G, Carrubba G, Blandino G, Strano S.

OMICS. 2011 Jun;15(6):337-46. doi: 10.1089/omi.2010.0086. Epub 2011 Feb 24. Review.

PMID:
21348760
29.

Stimulation of the nicotine antiinflammatory pathway improves food intake and body composition in tumor-bearing rats.

Molfino A, Logorelli F, Citro G, Bertini G, Ramaccini C, Bollea MR, Rossi Fanelli F, Laviano A.

Nutr Cancer. 2011;63(2):295-9. doi: 10.1080/01635581.2011.530736.

PMID:
21298590
30.

Coeliac children treated for growth hormone deficiency reach normal final height.

Meazza C, Pagani S, Messini B, Cardinale GM, Mastrangelo C, Citro G, Delvecchio M, Tinelli C, Corazza GR, Bozzola M.

Clin Endocrinol (Oxf). 2011 Jun;74(6):791-2. doi: 10.1111/j.1365-2265.2010.03960.x. No abstract available.

PMID:
21166689
31.

Electrochemotherapy treatment for bilateral pleomorphic rhabdomyosarcoma in a cat.

Spugnini EP, Filipponi M, Romani L, Dotsinsky I, Mudrov N, Citro G, Baldi A.

J Small Anim Pract. 2010 Jun;51(6):330-2. doi: 10.1111/j.1748-5827.2010.00913.x. Epub 2010 May 10.

PMID:
20492454
32.

Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.

Spugnini EP, Citro G, Fais S.

J Exp Clin Cancer Res. 2010 May 8;29:44. doi: 10.1186/1756-9966-29-44. Review.

33.

Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring.

Signorile PG, Spugnini EP, Mita L, Mellone P, D'Avino A, Bianco M, Diano N, Caputo L, Rea F, Viceconte R, Portaccio M, Viggiano E, Citro G, Pierantoni R, Sica V, Vincenzi B, Mita DG, Baldi F, Baldi A.

Gen Comp Endocrinol. 2010 Sep 15;168(3):318-25. doi: 10.1016/j.ygcen.2010.03.030. Epub 2010 Mar 27.

PMID:
20350546
34.

Cyproterone acetate-induced mammary carcinoma in two male cats.

Spugnini EP, Mezzanotte F, Freri L, Betti G, Citro G, Baldi A.

J Feline Med Surg. 2010 Jun;12(6):515-6. doi: 10.1016/j.jfms.2010.01.009. Epub 2010 Mar 12. No abstract available.

PMID:
20226707
35.

Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.

Crispi S, Cardillo I, Spugnini EP, Citro G, Menegozzo S, Baldi A.

Curr Cancer Drug Targets. 2010 Feb;10(1):19-26. Review.

PMID:
20088796
36.

Identification of multipotent cytotrophoblast cells from human first trimester chorionic villi.

Spitalieri P, Cortese G, Pietropolli A, Filareto A, Dolci S, Klinger FG, Giardina E, Di Cesare S, Bernardini L, Lauro D, Scaldaferri ML, Citro G, Novelli G, De Felici M, Sangiuolo F.

Cloning Stem Cells. 2009 Dec;11(4):535-56. doi: 10.1089/clo.2009.0046. Erratum in: Cloning Stem Cells. 2010 Feb;12(1):115. Scaldaferri, H Lucia [corrected to Scaldaferri, M Lucia].

PMID:
20025524
37.

Graft vascularization is a critical rate-limiting step in skeletal stem cell-mediated posterolateral spinal fusion.

Giannicola G, Ferrari E, Citro G, Sacchetti B, Corsi A, Riminucci M, Cinotti G, Bianco P.

J Tissue Eng Regen Med. 2010 Jun;4(4):273-83. doi: 10.1002/term.238.

PMID:
20013838
38.

Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target.

Crispi S, Calogero RA, Santini M, Mellone P, Vincenzi B, Citro G, Vicidomini G, Fasano S, Meccariello R, Cobellis G, Menegozzo S, Pierantoni R, Facciolo F, Baldi A, Menegozzo M.

PLoS One. 2009 Sep 15;4(9):e7016. doi: 10.1371/journal.pone.0007016.

39.

Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.

Spugnini EP, Citro G, Baldi A.

J Exp Clin Cancer Res. 2009 Aug 14;28:114. doi: 10.1186/1756-9966-28-114. Review.

40.

Insulin lispro protamine suspension in intensive insulin treatment: an Italian observational study.

Citro G, Lorusso B, Rossi A, Romaniello M, Gentilella R, Cremasco F.

Curr Med Res Opin. 2009 Sep;25(9):2259-65. doi: 10.1185/03007990903166474.

PMID:
19630489
41.

Respiratory disorders and hospitalization rates during the second RSV season in preterm infants who received palivizumab prophylaxis during their first RSV season.

Fanos V, Scarcella A, Puddu M, Gallini F, Tuminelli F, Bragetti P, Gallina MR, Quartulli L, Benincori N, Citro G, Via LD, Barera G, DI Luzio Paparatti U, Merolla R, Romano GV, Guida G, Silvestri M, Rossi GA.

J Chemother. 2009 Jun;21(3):302-10.

PMID:
19567351
42.

Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic function.

Felici A, Di Segni S, Milella M, Colantonio S, Sperduti I, Nuvoli B, Contestabile M, Sacconi A, Zaratti M, Citro G, Cognetti F.

Clin Pharmacokinet. 2009;48(2):131-41. doi: 10.2165/0003088-200948020-00005.

PMID:
19271785
43.

Adjuvant carboplatin for the treatment of intestinal carcinoid in a dog.

Spugnini EP, Gargiulo M, Assin R, D'Avino A, Mellone P, Citro G, Cardelli P, Baldi A.

In Vivo. 2008 Nov-Dec;22(6):759-61.

44.

Prostate as sole unusual recurrence site of lymphoma in a dog.

Assin R, Baldi A, Citro G, Spugnini EP.

In Vivo. 2008 Nov-Dec;22(6):755-7.

45.

Electrochemotherapy-induced radiation recall in a cat.

Spugnini EP, Dotsinsky I, Mudrov N, Citro G, Caruso G, Cardelli P, Baldi A.

In Vivo. 2008 Nov-Dec;22(6):751-3.

46.

Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma.

Spugnini EP, Dotsinsky I, Mudrov N, Citro G, D'Avino A, Baldi A.

J Exp Clin Cancer Res. 2008 Nov 3;27:58. doi: 10.1186/1756-9966-27-58.

47.

The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs.

Di Agostino S, Cortese G, Monti O, Dell'Orso S, Sacchi A, Eisenstein M, Citro G, Strano S, Blandino G.

Cell Cycle. 2008 Nov 1;7(21):3440-7. Epub 2008 Nov 16.

PMID:
18948736
48.

Identification of genes down-regulated during lung cancer progression: a cDNA array study.

Campioni M, Ambrogi V, Pompeo E, Citro G, Castelli M, Spugnini EP, Gatti A, Cardelli P, Lorenzon L, Baldi A, Mineo TC.

J Exp Clin Cancer Res. 2008 Sep 15;27:38. doi: 10.1186/1756-9966-27-38.

49.

Zoledronic acid for the treatment of appendicular osteosarcoma in a dog.

Spugnini EP, Vincenzi B, Caruso G, Baldi A, Citro G, Santini D, Tonini G.

J Small Anim Pract. 2009 Jan;50(1):44-6. doi: 10.1111/j.1748-5827.2008.00635.x. Epub 2008 Sep 12.

PMID:
18793253
50.

The serine protease HtrA1 is a novel prognostic factor for human mesothelioma.

Baldi A, Mottolese M, Vincenzi B, Campioni M, Mellone P, Di Marino M, di Crescenzo VG, Visca P, Menegozzo S, Spugnini EP, Citro G, Ceribelli A, Mirri A, Chien J, Shridhar V, Ehrmann M, Santini M, Facciolo F.

Pharmacogenomics. 2008 Aug;9(8):1069-77. doi: 10.2217/14622416.9.8.1069.

PMID:
18681782

Supplemental Content

Support Center